BTK drugs for Chronic Lymphocytic Leukemia
4 tracked BTK drugs in the Chronic Lymphocytic Leukemia race. The class explanation lives on the BTK page; the full indication pipeline across every mechanism is on the Chronic Lymphocytic Leukemia page.
4 approved / phase 4
Head-to-head evidence: Acalabrutinib vs Ibrutinib · Acalabrutinib vs Pirtobrutinib · Acalabrutinib vs zanubrutinib · Ibrutinib vs Pirtobrutinib · Ibrutinib vs zanubrutinib · Pirtobrutinib vs zanubrutinib